| content | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (February 2007) |
 |
|
 |
|
|
Oxiracetam
|
|
| Systematic (IUPAC) name | |
| 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide | |
| Identifiers | |
| CAS number | |
| ATC code | N06 |
| PubChem | |
| Chemical data | |
| Formula | C6H10N2O3 |
| Mol. mass | 158.155 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Unscheduled (US) |
| Routes | Oral |
Oxiracetam is a nootropic drug of the racetam family.
Several animal studies suggest that the substance is safe even when high doses are consumed for a long period of time. However the mechanism of action of oxiracetam is still a matter of research.
External links
See also
|
|||||
|
||||||||||||||||||||||||||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
